Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengling Li

Showing results (191-200 of 253) with videos related to

Pageof 26
Sort By:
Journal of Medicinal Chemistry|January 30, 2016
Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment InhibitorRenato Ferreira de Freitas, Mohammad S Eram, Magdalena M Szewczyk, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Probing the SAM Binding Site of SARS-CoV-2 nsp14 in vitro Using SAM Competitive Inhibitors Guides Developing Selective bi-substrate InhibitorsKanchan Devkota, Matthieu Schapira, Sumera Perveen, et al.
Nature Communications|April 25, 2019
A chemical toolbox for the study of bromodomains and epigenetic signalingQin Wu, David Heidenreich, Stanley Zhou, et al.
Chemmedchem|June 24, 2021
Development of LM98, a Small-Molecule TEAD Inhibitor Derived from Flufenamic AcidLéa Mélin, Shuay Abdullayev, Ahmed Fnaiche, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 23, 2018
Discovery of Small-Molecule Antagonists of the H3K9me3 Binding to UHRF1 Tandem Tudor DomainGuillermo Senisterra, Hugh Y Zhu, Xiao Luo, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 1, 2021
Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate InhibitorsKanchan Devkota, Matthieu Schapira, Sumera Perveen, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor ActivityZahid Q Bonday, Guillermo S Cortez, Michael J Grogan, et al.
ACS Chemical Biology|November 25, 2015
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine MethyltransferasesMohammad S Eram, Yudao Shen, Magdalena Szewczyk, et al.
European Journal of Medicinal Chemistry|March 8, 2026
Identification and optimization of first-in-class RNA helicase inhibitors of DDX1, LGP2, and MDA5Xiaowen Wang, Feijun Wang, Deyu Kong, et al.
SLAS Discovery : Advancing Life Sciences R & D|October 22, 2022
Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded libraryDevan J Shell, Justin M Rectenwald, Peter H Buttery, et al.
Pageof 26

Showing results (191-200 of 253) with videos related to

Sort By:
Pageof 26
Journal of Medicinal Chemistry|January 30, 2016
Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment InhibitorRenato Ferreira de Freitas, Mohammad S Eram, Magdalena M Szewczyk, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Probing the SAM Binding Site of SARS-CoV-2 nsp14 in vitro Using SAM Competitive Inhibitors Guides Developing Selective bi-substrate InhibitorsKanchan Devkota, Matthieu Schapira, Sumera Perveen, et al.
Nature Communications|April 25, 2019
A chemical toolbox for the study of bromodomains and epigenetic signalingQin Wu, David Heidenreich, Stanley Zhou, et al.
Chemmedchem|June 24, 2021
Development of LM98, a Small-Molecule TEAD Inhibitor Derived from Flufenamic AcidLéa Mélin, Shuay Abdullayev, Ahmed Fnaiche, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 23, 2018
Discovery of Small-Molecule Antagonists of the H3K9me3 Binding to UHRF1 Tandem Tudor DomainGuillermo Senisterra, Hugh Y Zhu, Xiao Luo, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 1, 2021
Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate InhibitorsKanchan Devkota, Matthieu Schapira, Sumera Perveen, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor ActivityZahid Q Bonday, Guillermo S Cortez, Michael J Grogan, et al.
ACS Chemical Biology|November 25, 2015
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine MethyltransferasesMohammad S Eram, Yudao Shen, Magdalena Szewczyk, et al.
European Journal of Medicinal Chemistry|March 8, 2026
Identification and optimization of first-in-class RNA helicase inhibitors of DDX1, LGP2, and MDA5Xiaowen Wang, Feijun Wang, Deyu Kong, et al.
SLAS Discovery : Advancing Life Sciences R & D|October 22, 2022
Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded libraryDevan J Shell, Justin M Rectenwald, Peter H Buttery, et al.
Pageof 26